{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T03:15:13Z","timestamp":1769742913225,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bmcl.2021.128290","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T09:33:55Z","timestamp":1627032835000},"page":"128290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Development of succinimide-based inhibitors for the mitochondrial rhomboid protease PARL"],"prefix":"10.1016","volume":"49","author":[{"given":"William H.","family":"Parsons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas T.","family":"Rutland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Crainic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquin M.","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa S.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte L.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan K.","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bmcl.2021.128290_b0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev-biochem-060713-035708","article-title":"Enzyme inhibitor discovery by activity-based protein profiling","volume":"83","author":"Niphakis","year":"2014","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bmcl.2021.128290_b0010","series-title":"Current Topics in Microbiology and Immunology","first-page":"253","article-title":"Recent advances in activity-based protein profiling of proteases","author":"Chakrabarty","year":"2019"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128290_b0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrd3620","article-title":"The pharmacological landscape and therapeutic potential of serine hydrolases","volume":"11","author":"Bachovchin","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.bmcl.2021.128290_b0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.chembiol.2020.07.008","article-title":"Strategies for tuning the selectivity of chemical probes that target serine hydrolases","volume":"27","author":"Faucher","year":"2020","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.bmcl.2021.128290_b0025","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/bs.mie.2016.10.014","article-title":"Mechanism and inhibition of rhomboid proteases","author":"Strisovsky","year":"2017"},{"key":"10.1016\/j.bmcl.2021.128290_b0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biochi.2015.07.007","article-title":"Inhibitors of rhomboid proteases","volume":"122","author":"Wolf","year":"2016","journal-title":"Biochimie"},{"issue":"22","key":"10.1016\/j.bmcl.2021.128290_b0035","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1038\/emboj.2010.243","article-title":"The structural basis for catalysis and substrate specificity of a rhomboid protease","volume":"29","author":"Vinothkumar","year":"2010","journal-title":"EMBO J"},{"issue":"7","key":"10.1016\/j.bmcl.2021.128290_b0040","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1073\/pnas.1215076110","article-title":"Activity-based probes for rhomboid proteases discovered in a mass spectrometry-based assay","volume":"110","author":"Vosyka","year":"2013","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128290_b0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1021\/cb100314y","article-title":"Monocyclic \u03b2-lactams are selective, mechanism-based inhibitors of rhomboid intramembrane proteases","volume":"6","author":"Pierrat","year":"2011","journal-title":"ACS Chem Biol"},{"issue":"8","key":"10.1016\/j.bmcl.2021.128290_b0050","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bmcl.2018.02.017","article-title":"Discovery and validation of 2-styryl substituted benzoxazin-4-ones as a novel scaffold for rhomboid protease inhibitors","volume":"28","author":"Goel","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"10.1016\/j.bmcl.2021.128290_b0055","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.bmcl.2017.12.056","article-title":"Benzoxazin-4-ones as novel, easily accessible inhibitors for rhomboid proteases","volume":"28","author":"Yang","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"issue":"51","key":"10.1016\/j.bmcl.2021.128290_b0060","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1021\/acs.biochem.7b01066","article-title":"Discovery and biological evaluation of potent and selective N-methylene saccharin-derived inhibitors for rhomboid intramembrane proteases","volume":"56","author":"Goel","year":"2017","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128290_b0065","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.molcel.2015.12.022","article-title":"Crystal structures and inhibition kinetics reveal a two-stage catalytic mechanism with drug design implications for rhomboid proteolysis","volume":"61","author":"Cho","year":"2016","journal-title":"Mol Cell"},{"issue":"12","key":"10.1016\/j.bmcl.2021.128290_b0070","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.chembiol.2017.09.007","article-title":"General and modular strategy for designing potent, selective, and pharmacologically compliant inhibitors of rhomboid proteases","volume":"24","author":"Tich\u00e1","year":"2017","journal-title":"Cell Chem Biol"},{"issue":"10","key":"10.1016\/j.bmcl.2021.128290_b0075","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1021\/acschembio.5b00514","article-title":"Inhibitor fingerprinting of rhomboid proteases by activity-based protein profiling reveals inhibitor selectivity and rhomboid autoprocessing","volume":"10","author":"Wolf","year":"2015","journal-title":"ACS Chem Biol"},{"issue":"11","key":"10.1016\/j.bmcl.2021.128290_b0080","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.chembiol.2020.08.011","article-title":"Designed parasite-selective rhomboid inhibitors block invasion and clear blood-stage malaria","volume":"27","author":"Gandhi","year":"2020","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.bmcl.2021.128290_b0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.semcdb.2016.07.034","article-title":"PARL: The mitochondrial rhomboid protease","volume":"60","author":"Spinazzi","year":"2016","journal-title":"Semin Cell Dev Biol"},{"issue":"18","key":"10.1016\/j.bmcl.2021.128290_b0090","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1016\/j.jmb.2020.04.006","article-title":"PARL protease: a glimpse at intramembrane proteolysis in the inner mitochondrial membrane","volume":"432","author":"Lysyk","year":"2020","journal-title":"J Mol Biol"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128290_b0095","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1083\/jcb.201008084","article-title":"Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL","volume":"191","author":"Jin","year":"2010","journal-title":"J Cell Biol"},{"issue":"41","key":"10.1016\/j.bmcl.2021.128290_b0100","doi-asserted-by":"crossref","first-page":"34635","DOI":"10.1074\/jbc.M112.357509","article-title":"Rhomboid protease PARL mediates the mitochondrial membrane potential loss-induced cleavage of PGAM5","volume":"287","author":"Sekine","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2021.128290_b0105","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201797909","article-title":"PARL partitions the lipid transfer protein STARD7 between the cytosol and mitochondria","volume":"37","author":"Saita","year":"2018","journal-title":"EMBO J"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128290_b0110","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncb3488","article-title":"PARL mediates Smac proteolytic maturation in mitochondria to promote apoptosis","volume":"19","author":"Saita","year":"2017","journal-title":"Nat Cell Biol"},{"issue":"15","key":"10.1016\/j.bmcl.2021.128290_b0115","doi-asserted-by":"crossref","first-page":"15323","DOI":"10.1074\/jbc.M313756200","article-title":"Self-regulated cleavage of the mitochondrial intramembrane-cleaving protease PARL yields P\u03b2, a nuclear-targeted peptide","volume":"279","author":"S\u00edk","year":"2004","journal-title":"J Biol Chem"},{"issue":"49","key":"10.1016\/j.bmcl.2021.128290_b0120","doi-asserted-by":"crossref","first-page":"18562","DOI":"10.1073\/pnas.0604983103","article-title":"Phosphorylation and cleavage of presenilin-associated rhomboid-like protein (PARL) promotes changes in mitochondrial morphology","volume":"103","author":"Jeyaraju","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.bmcl.2021.128290_b0125","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/cdd.2011.22","article-title":"Structural and mechanistic basis of Parl activity and regulation","volume":"18","author":"Jeyaraju","year":"2011","journal-title":"Cell Death Differ"},{"issue":"3","key":"10.1016\/j.bmcl.2021.128290_b0130","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1085\/jgp.201812047","article-title":"The rhomboid protease GlpG has weak interaction energies in its active site hydrogen bond network","volume":"151","author":"Gaffney","year":"2019","journal-title":"J Gen Physiol"},{"issue":"5","key":"10.1016\/j.bmcl.2021.128290_b0135","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1074\/jbc.M111.310482","article-title":"Catalytic mechanism of rhomboid protease GlpG probed by 3,4-dichloroisocoumarin and diisopropyl fluorophosphonate","volume":"287","author":"Xue","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2021.128290_b0140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2174\/138161280505230110110545","article-title":"Succinimide and saccharin-based enzyme-activated inhibitors of serine proteases","volume":"5","author":"Martyn","year":"1999","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmcl.2021.128290_b0145","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1021\/ja00187a086","article-title":"13C NMR evidence for an enzyme-induced Lossen rearrangement in the mechanism-based inactivation of alpha-chymotrypsin by 3-benzyl-N-((methylsulfonyl)oxy)succinimide","volume":"111","author":"Groutas","year":"1989","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2021.128290_b0150","unstructured":"Benson KE, David MM, Kipke CA, Lakshmi BB, Leir CM, Moore GG, Shah R. N-Sulfonyldicarboximide containing tethering compounds; 2008. US7351838B2."},{"issue":"2","key":"10.1016\/j.bmcl.2021.128290_b0155","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1021\/je60045a007","article-title":"Synthesis of N-alkyl- and N-arylsulfonylphthalimides from potassium phthalimide and sulfonyl chlorides","volume":"15","author":"Heller","year":"1970","journal-title":"J Chem Eng Data"},{"key":"10.1016\/j.bmcl.2021.128290_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100383","article-title":"Insights into the catalytic properties of the mitochondrial rhomboid protease PARL","volume":"296","author":"Lysyk","year":"2021","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.bmcl.2021.128290_b0165","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.bbamem.2013.05.012","article-title":"The mitochondrial rhomboid protease: its rise from obscurity to the pinnacle of disease-relevant genes","volume":"1828","author":"Chan","year":"2013","journal-title":"Biochim Biophys Acta - Biomembr"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128290_b0170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1073\/pnas.1811938116","article-title":"PARL deficiency in mouse causes complex III defects, coenzyme Q depletion, and leigh-like syndrome","volume":"116","author":"Spinazzi","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128290_b0175","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1038\/ncomms9022","article-title":"Rhomboid domain containing 1 promotes colorectal cancer growth through activation of the EGFR signalling pathway","volume":"6","author":"Song","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128290_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-018-0267-5","article-title":"Rhomboid domain-containing protein 1 promotes breast cancer progression by regulating the p-Akt and CDK2 Levels","volume":"16","author":"Zhang","year":"2018","journal-title":"Cell Commun Signal"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128290_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-9966-31-1","article-title":"RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1","volume":"37","author":"Zhang","year":"2018","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21005175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21005175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:41:26Z","timestamp":1760773286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21005175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":37,"alternative-id":["S0960894X21005175"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128290","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of succinimide-based inhibitors for the mitochondrial rhomboid protease PARL","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128290","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128290"}}